MedTrace Logo

Efficacy Study of Botox to Treat Neuropathic Pain

NCT00527202 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 29

Last updated 2021-05-05

No results posted yet for this study

Summary

Objectives : to investigate the analgesic effects and safety of intradermal botulinum toxin A injection in the treatment of focal painful neuropathies (eg, postherpetic neuralgia, nerve trauma)

Conditions

  • Postherpetic Neuralgia
  • Nerve Trauma

Interventions

DRUG

botulinum toxin A

Botulinum toxin A versus saline in parallel groups

Sponsors & Collaborators

  • Hospital Ambroise Paré Paris

    lead OTHER

Principal Investigators

  • Didier BOUHASSIRA, MD, PHD · INSERM U 792

  • Danièle RANOUX, MD · hôpital de Limoges (FRANCE)

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-06-30
Primary Completion
2007-03-31
Completion
2007-03-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00527202 on ClinicalTrials.gov